Pilot study of the conversion from tacrolimus to cyclosporine microemulsion in liver transplant patients presenting with new onset diabetes after the 3rd month post-transplant

Trial Profile

Pilot study of the conversion from tacrolimus to cyclosporine microemulsion in liver transplant patients presenting with new onset diabetes after the 3rd month post-transplant

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Jan 2011

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Liver transplant rejection
  • Focus Adverse reactions
  • Sponsors Novartis
  • Most Recent Events

    • 31 Jan 2011 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
    • 31 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top